(Q49158742)

18 February 2018

title

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. (English)

1 reference

18 February 2018

1 reference

10

1 reference

18 February 2018

Pamela M. Pollock

13

1 reference

18 February 2018

Tjalling Bosse

Tjalling Bosse

2

0 references

David N Church

David N Church

5

0 references

Alexandra Leary

Alexandra Leary

7

0 references

Carien L Creutzberg

Carien L Creutzberg

15

0 references

author name string

Ellen Stelloo

1

1 reference

18 February 2018

Remi A Nout

3

1 reference

18 February 2018

Helen J MacKay

4

1 reference

18 February 2018

Hans W Nijman

6

1 reference

18 February 2018

Richard J Edmondson

8

1 reference

18 February 2018

Melanie E Powell

9

1 reference

18 February 2018

Henry C Kitchener

11

1 reference

18 February 2018

Linda Mileshkin

12

1 reference

18 February 2018

Vincent T Smit

14

1 reference

18 February 2018

publication date

27 February 2015

1 reference

18 February 2018

published in

Modern Pathology

1 reference

18 February 2018

volume

28

1 reference

18 February 2018

issue

6

1 reference

18 February 2018

page(s)

836-844

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2015.43

exact match

0 references

cites work

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Emerging therapeutic targets in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Classification of endometrial carcinoma: more than two types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

The emerging genomic landscape of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Prognostic significance of POLE proofreading mutations in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

FGFR2 as a molecular target in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

The target therapy of ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Molecular characterization of uterine clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.43

Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importance

21 January 2018

1 reference

12 December 2020

Past, present, and future of hormonal therapy in recurrent endometrial cancer

1 reference

12 December 2020

Microsatellite Instability and Epigenetic Inactivation ofMLH1and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type

1 reference

12 December 2020

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma

1 reference

12 December 2020

Reproducibility of histological cell type in high-grade endometrial carcinoma

1 reference

12 December 2020

Interobserver agreement for tumour type, grade of differentiation and stage in endometrial carcinomas

1 reference

12 December 2020

Targeted mutation analysis of endometrial clear cell carcinoma.

1 reference

12 December 2020

Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes

1 reference

12 December 2020

10.1038/MODPATHOL.2015.43

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

1050140887

0 references

1 reference

18 February 2018